Goldman Sachs
PRAH

Goldman Sachs’s PRA Health Sciences, Inc. PRAH Stock Holding History

Goldman Sachs’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-45,000
Closed -$1.88M – 7257
2016
Q2 		$1.88M Hold
45,000
– – ﹤0.01% 3676
2016
Q1 		$1.92M Buy
+45,000
New +$1.9M ﹤0.01% 3504

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Goldman Sachs's PRAH Position: Q3 2021 in Review

Goldman Sachs sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,346,352 shares — an estimated $222M sold.

Goldman Sachs first reported a position in PRAH in Q1 2015 and held it in 25 quarters. The position peaked at $222M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Goldman Sachs reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 1,346,352 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $222M.
  • Goldman Sachs first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 25 quarters.
  • Goldman Sachs's PRA Health Sciences, Inc. position peaked at $222M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.